vs

Side-by-side financial comparison of SelectQuote, Inc. (SLQT) and WORTHINGTON ENTERPRISES, INC. (WOR). Click either name above to swap in a different company.

SelectQuote, Inc. is the larger business by last-quarter revenue ($537.1M vs $327.5M, roughly 1.6× WORTHINGTON ENTERPRISES, INC.). SelectQuote, Inc. runs the higher net margin — 12.9% vs 8.3%, a 4.6% gap on every dollar of revenue. On growth, WORTHINGTON ENTERPRISES, INC. posted the faster year-over-year revenue change (19.5% vs 11.6%). WORTHINGTON ENTERPRISES, INC. produced more free cash flow last quarter ($39.1M vs $-1.0M).

SelectQuote is a direct-to-consumer distribution platform for selling insurance policies and healthcare services. Their insurance business earns commissions by connecting consumers with insurance carriers that provide senior health, life, automobile, and home insurance. The healthcare services business mainly consists of SelectRx, an accredited pharmacy. The company went public on May 21, 2020.

Worthington Enterprises, Inc. is an American industrial manufacturing company headquartered in Columbus, Ohio. The company is composed of two business segments, consumer products and building products. Within these segments, the company designs and manufactures pressure vessels such as propane, oxygen and helium tanks, refrigerant and industrial cylinders, camping and residential use cylinders, water system tanks for storage, treatment, heating, expansion and flow control, as well as a variet...

SLQT vs WOR — Head-to-Head

Bigger by revenue
SLQT
SLQT
1.6× larger
SLQT
$537.1M
$327.5M
WOR
Growing faster (revenue YoY)
WOR
WOR
+7.8% gap
WOR
19.5%
11.6%
SLQT
Higher net margin
SLQT
SLQT
4.6% more per $
SLQT
12.9%
8.3%
WOR
More free cash flow
WOR
WOR
$40.1M more FCF
WOR
$39.1M
$-1.0M
SLQT

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
SLQT
SLQT
WOR
WOR
Revenue
$537.1M
$327.5M
Net Profit
$69.3M
$27.3M
Gross Margin
61.8%
25.8%
Operating Margin
14.0%
3.7%
Net Margin
12.9%
8.3%
Revenue YoY
11.6%
19.5%
Net Profit YoY
30.2%
-3.3%
EPS (diluted)
$0.26
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SLQT
SLQT
WOR
WOR
Q4 25
$537.1M
$327.5M
Q3 25
$328.8M
$303.7M
Q2 25
$345.1M
Q1 25
$408.2M
Q4 24
$481.1M
Q3 24
$292.3M
Q2 24
$307.2M
Q1 24
$376.4M
Net Profit
SLQT
SLQT
WOR
WOR
Q4 25
$69.3M
$27.3M
Q3 25
$-30.5M
$35.1M
Q2 25
$12.9M
Q1 25
$26.0M
Q4 24
$53.2M
Q3 24
$-44.5M
Q2 24
$-31.0M
Q1 24
$8.6M
Gross Margin
SLQT
SLQT
WOR
WOR
Q4 25
61.8%
25.8%
Q3 25
41.4%
27.1%
Q2 25
47.2%
Q1 25
60.2%
Q4 24
67.5%
Q3 24
55.7%
Q2 24
60.7%
Q1 24
71.8%
Operating Margin
SLQT
SLQT
WOR
WOR
Q4 25
14.0%
3.7%
Q3 25
-12.4%
3.0%
Q2 25
-3.6%
Q1 25
5.4%
Q4 24
14.7%
Q3 24
-4.1%
Q2 24
-0.5%
Q1 24
8.8%
Net Margin
SLQT
SLQT
WOR
WOR
Q4 25
12.9%
8.3%
Q3 25
-9.3%
11.6%
Q2 25
3.7%
Q1 25
6.4%
Q4 24
11.1%
Q3 24
-15.2%
Q2 24
-10.1%
Q1 24
2.3%
EPS (diluted)
SLQT
SLQT
WOR
WOR
Q4 25
$0.26
$0.55
Q3 25
$-0.26
$0.70
Q2 25
$-0.06
Q1 25
$0.03
Q4 24
$0.30
Q3 24
$-0.26
Q2 24
$-0.17
Q1 24
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SLQT
SLQT
WOR
WOR
Cash + ST InvestmentsLiquidity on hand
$18.3M
$180.3M
Total DebtLower is stronger
$405.8M
Stockholders' EquityBook value
$359.7M
$962.6M
Total Assets
$1.4B
$1.8B
Debt / EquityLower = less leverage
1.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SLQT
SLQT
WOR
WOR
Q4 25
$18.3M
$180.3M
Q3 25
$10.7M
$167.1M
Q2 25
$32.4M
Q1 25
$80.1M
Q4 24
$7.3M
Q3 24
$10.4M
Q2 24
$42.7M
Q1 24
$37.8M
Total Debt
SLQT
SLQT
WOR
WOR
Q4 25
$405.8M
Q3 25
$393.1M
Q2 25
$385.1M
Q1 25
$391.5M
Q4 24
$711.9M
Q3 24
$680.4M
Q2 24
$683.3M
Q1 24
$686.0M
Stockholders' Equity
SLQT
SLQT
WOR
WOR
Q4 25
$359.7M
$962.6M
Q3 25
$305.1M
$959.1M
Q2 25
$351.1M
Q1 25
$350.2M
Q4 24
$326.0M
Q3 24
$269.4M
Q2 24
$316.8M
Q1 24
$346.8M
Total Assets
SLQT
SLQT
WOR
WOR
Q4 25
$1.4B
$1.8B
Q3 25
$1.2B
$1.7B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.1B
Q2 24
$1.2B
Q1 24
$1.2B
Debt / Equity
SLQT
SLQT
WOR
WOR
Q4 25
1.13×
Q3 25
1.29×
Q2 25
1.10×
Q1 25
1.12×
Q4 24
2.18×
Q3 24
2.53×
Q2 24
2.16×
Q1 24
1.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SLQT
SLQT
WOR
WOR
Operating Cash FlowLast quarter
$52.0K
$51.5M
Free Cash FlowOCF − Capex
$-1.0M
$39.1M
FCF MarginFCF / Revenue
-0.2%
11.9%
Capex IntensityCapex / Revenue
0.2%
3.8%
Cash ConversionOCF / Net Profit
0.00×
1.89×
TTM Free Cash FlowTrailing 4 quarters
$8.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SLQT
SLQT
WOR
WOR
Q4 25
$52.0K
$51.5M
Q3 25
$-21.6M
$41.1M
Q2 25
$-37.5M
Q1 25
$71.1M
Q4 24
$-28.7M
Q3 24
$-16.6M
Q2 24
$20.0M
Q1 24
$44.5M
Free Cash Flow
SLQT
SLQT
WOR
WOR
Q4 25
$-1.0M
$39.1M
Q3 25
$-22.7M
$27.9M
Q2 25
$-38.0M
Q1 25
$70.2M
Q4 24
$-29.0M
Q3 24
$-17.1M
Q2 24
$19.7M
Q1 24
$43.4M
FCF Margin
SLQT
SLQT
WOR
WOR
Q4 25
-0.2%
11.9%
Q3 25
-6.9%
9.2%
Q2 25
-11.0%
Q1 25
17.2%
Q4 24
-6.0%
Q3 24
-5.8%
Q2 24
6.4%
Q1 24
11.5%
Capex Intensity
SLQT
SLQT
WOR
WOR
Q4 25
0.2%
3.8%
Q3 25
0.3%
4.3%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
0.1%
Q1 24
0.3%
Cash Conversion
SLQT
SLQT
WOR
WOR
Q4 25
0.00×
1.89×
Q3 25
1.17×
Q2 25
-2.91×
Q1 25
2.73×
Q4 24
-0.54×
Q3 24
Q2 24
Q1 24
5.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SLQT
SLQT

Healthcare Services Segment$230.7M43%
Pharmacy$227.2M42%
Other$30.4M6%
Final Expense$20.4M4%
Term$18.5M3%
Other Senior$6.3M1%
All Other Revenue$3.9M1%

WOR
WOR

Building Products$207.5M63%
Equity Method Investment Nonconsolidated Investee Other$120.7M37%

Related Comparisons